• Jump to content
  • RSS News Feed
  • Member Login
Medicines Australia

Medicines Australia

  • Home
  • About Us
  • Media | Events
  • Issues | Information
  • Code of Conduct
  • Links
  • You are here:
  • Home
  • Code of Conduct
  • Education Events Reports
  • Previous Reports
  • January – June 2009

Code of Conduct

  • Code of Conduct – Current Edition
    • Archived Codes of Conduct
  • Lodging & Responding to a Code of Conduct Complaint
  • Code of Conduct Review
    • Archived Code of Conduct Reviews
    • Submissions to 2011/2012 Code Review
  • Code and Monitoring Committee Meeting Dates
  • Committee Membership
  • Code of Conduct Reports
  • Education Events Reports
    • Member Company Reports
    • Glossary
    • Frequently Asked Questions
    • Useful Links
    • Previous Reports
      • Oct 2010 – March 2011
      • April – September 2010
      • January – March 2010
      • July – December 2009
      • January – June 2009
      • July – December 2008
      • January – June 2008
      • July – December 2007
  • Continuing Education Program (CEP)

January – June 2009

Companies are listed in alphabetical order

1 January – 30 June 2009

  • Abbott Australasia 53k
  • Actelion 21k
  • Alcon Pharmaceuticals 240k
  • Allergan 66k
  • AMGEN Australia 179k
  • AstraZeneca 420k
  • Baxter Healthcare 201k
  • Bayer Australia 66k
  • Biogen Idec Australia 147k
  • Boehringer Ingelheim 310k
  • Bristol-Myers Squibb Australia 59k
  • Celgene Pty Ltd 14k
  • CSL Limited 15684k
  • Eli Lilly Australia 275k
  • Genzyme Australasia Pty Ltd 34k
  • Gilead Sciences 48k
  • GlaxoSmithKline Australia 151k
  • Innovex 28k
  • iNova Pharmaceuticals 20k
  • Ipsen 57k
  • Janssen-Cilag 177k
  • Lundbeck 78k
  • Merck Serono 50k
  • Merck Sharp & Dohme 91k
  • Mundipharma 49k
  • Norgine 48k
  • Novartis Pharmaceuticals 275k
  • Novo Nordisk 266k
  • Nycomed 44k
  • Pfizer 302k
  • Roche Products 209k
  • sanofi-aventis 8018k
  • sanofi-pasteur 18k
  • Schering-Plough 324k
  • Servier Laboratories 178k
  • Shire Australia 39k
  • Solvay Pharmaceuticals 61k
  • Stiefel Laboratories 21k
  • UCB Pharma 102k
  • Wyeth 121k

Previous Educational Event Reports

Page updated: December 2011

Back to top

© 2012 Medicines Australia


  • Copyright Statement
  • Disclaimer Statement
  • Privacy Statement

Level 1, 16 Napier Close
Deakin, ACT, 2600, Australia

Work: +61 2 6122 8500   Fax: +61 2 6122 8555
Email: info@medicinesaustralia.com.au